FGO for Applicants

HHS logo

Investigation of Potential Long-Term Effects of Stimulant ADHD Treatments in Non-Human Primates





General Information

Document Type: Modification to a Previous Grants Notice
Funding Opportunity Number: PAR-04-160
Posted Date: Oct 13, 2004
Original Due Date for Applications: Multiple Receipt Dates - See Link to Full Announcement for details.
Current Due Date for Applications: Dec 21, 2004
Archive Date: Jan 20, 2005
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Expected Number of Awards: Not Available.
Estimated Total Program Funding: Not Available.
Award Ceiling: none
Award Floor: none
CFDA Number: 93.242 -- Mental Health Research Grants
Cost Sharing or Matching Requirement: No

Eligible Applicants

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Eligible agencies of the Federal Government are eligible to apply.
Foreign institutions are not eligible to apply for this PA but can participate as a subcontract within a U01

Agency Name

Department of Health and Human Services, National Institutes of Health, National Institutes of Health

Description

he National Institute of Mental Health (NIMH) requests research grant applications to examine the possible long-term effects of therapeutic doses of orally administered Methylphenidate (MPH) and amphetamine (AMPH) on the brain when administered to juvenile non-human primates.There are no funds specifically dedicated to this initiative. One to two awards to responsive applications are anticipated. This PAR will use the NIH U01 Cooperative agreement award mechanism. Applications are allowed from single institutions with or without consortium agreements with other institutions for the performance of specified study components. For-profit or non-profit organizations, public or private institutions are eligible to apply. Foreign institutions are not eligible to apply for this PAR but can participate as a subcontract. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institutio!
n to develop an application for support. Applicants may submit only one application in response to this PAR. However, subcontract or consortium partners may be listed as collaborators on more than one application. Application materials are available at http://grants.nih.gov/grants/funding/phs398/phs398.html.

Link to Full Announcement

http://grants.nih.gov/grants/guide/pa-files/PAR-04-160.html

If you have difficulty accessing the full announcement electronically, please contact:

Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov Webmaster, NIH

You may return to Grants Opportunities at:
[Home] [SEARCH synopses]